Why is 3B Blackbio DX Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 8.89% and Operating profit at -1.53% over the last 5 years
2
Stock is technically in a Mildly Bearish range
- The technical trend has deteriorated from Sideways on 19-Nov-26
- The stocks Bollinger Band and KST technical factors are also Bearish
3
With ROE of 16.9, it has a Very Expensive valuation with a 3.2 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -0.42%, its profits have risen by 19.4% ; the PEG ratio of the company is 1
4
Despite the size of the company, domestic mutual funds hold only 0% of the company
- Domestic mutual funds have capability to do in-depth on-the-ground research on companies- their small stake may signify either they are not comfortable at the price or the business
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is 3B Blackbio for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
3B Blackbio
-0.42%
-0.01
53.92%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
8.89%
EBIT Growth (5y)
-1.53%
EBIT to Interest (avg)
40.05
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
0.39
Tax Ratio
25.00%
Dividend Payout Ratio
7.19%
Pledged Shares
0
Institutional Holding
4.79%
ROCE (avg)
22.82%
ROE (avg)
15.62%
Valuation Key Factors 
Factor
Value
P/E Ratio
19
Industry P/E
23
Price to Book Value
3.21
EV to EBIT
19.18
EV to EBITDA
16.93
EV to Capital Employed
4.15
EV to Sales
6.04
PEG Ratio
0.98
Dividend Yield
0.38%
ROCE (Latest)
21.64%
ROE (Latest)
16.87%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
12What is working for the Company
NET SALES(Q)
At Rs 48.28 cr has Grown at 42.42%
OPERATING PROFIT TO NET SALES(Q)
Highest at 43.62%
PBT LESS OI(Q)
At Rs 19.59 cr has Grown at 38.84%
PAT(Q)
At Rs 17.80 cr has Grown at 21.0%
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for 3B Blackbio
Net Sales - Quarterly
At Rs 48.28 cr has Grown at 42.42%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 43.62%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 19.59 cr has Grown at 38.84%
Year on Year (YoY)MOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 17.80 cr has Grown at 21.0%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)